This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Microbix Biosystems Inc.
8/13/2026
Good morning, everyone. Thanks for joining us today. We have a webinar with Microbix who just reported their Q3 results this morning. Good results showing progress in the business. With me today, I have Cameron Groome, CEO, Jim Currie, CFO, and Ken Hughes, COO. I don't believe that we'll be working off a presentation, but this session will contain forward-looking statements. If you'd like to know more about those, you can find them on the company's presentation on their website. And the format today is going to be a quick overview of the quarter and some other key items. And then we're going to get into Q&A. So if anyone has a question, feel free to enter that in the Q&A box at the bottom of your screen. And with that all out of the way, congrats, gentlemen.
Well, thank you. Thank you very much, Deborah. Appreciate it.
And Cameron, I think I'll turn the mic over to you.
You're reading a preview of the MBX Q3 2026 earnings call.
Free account.